Idenix gains on CV safety data for IDX184

Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) gained $0.48 (12%) to $4.65 on Monday after reporting that once-daily 50 and 100

Read the full 185 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE